• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Dual function of the hemagglutinin H5 fused to chicken CD154 in a potential strategy of DIVA against avian influenza disease: preliminary study

tetano

Editor, Senior Moderator
Open Vet J. 2015;5(2):138-147. Epub 2015 Sep 23.
[h=1]Dual function of the hemagglutinin H5 fused to chicken CD154 in a potential strategy of DIVA against avian influenza disease: preliminary study.[/h] Pose AG[SUP]1[/SUP], Rodr?guez ES[SUP]1[/SUP], M?ndez AC[SUP]2[/SUP], G?mez JN[SUP]3[/SUP], Redondo AV[SUP]3[/SUP], Rodr?guez ER[SUP]1[/SUP], Ramos EM[SUP]1[/SUP], Guti?rrez A?[SUP]1[/SUP], Molt? MP[SUP]1[/SUP], Roche DG[SUP]1[/SUP], Ugalde YS[SUP]4[/SUP], L?pez AM[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] In this study we demonstrated that the vaccine candidate against avian influenza virus H5N1 based on the hemagglutinin H5 (HA) fused to the chicken CD154 (HACD) can also be used for differentiating infected from vaccinated animals (DIVA). As the strategy of DIVA requires at least two proteins, we obtained a variant of the nucleoprotein (NP[SUB]49-375[/SUB]) in E. coli. After its purification by IMAC, the competence of the proteins NP[SUB]49-375[/SUB] and HACD as coating antigens in indirect ELISA assays were tested by using the sera of chickens immunized with the proteins HA and HACD and the reference sera from several avian influenza subtypes. Together with these sera, the sera from different species of birds and the sera of chickens infected with other avian viral diseases were analyzed by competition ELISA assays coated with the proteins NP[SUB]49-375[/SUB] and HACD. The results showed that the segment CD154 in the chimeric protein HACD did not interfere with the recognition of the molecule HA by its specific antibodies. Also, we observed variable detection levels when the reference sera were analyzed in the ELISA plates coated with the protein NP[SUB]49-375[/SUB]. Moreover, only the antibodies of the reference serum subtype H5 were detected in the ELISA plates coated with the protein HACD. The competition ELISA assays showed percentages of inhibition of 88-91% for the positives sera and less than 20% for the negative sera. We fixed the cut-off value of these assays at 25%. No antibody detection was observed in the sera from different species of birds or the sera of chickens infected with other avian viral diseases. This study supported the fact that the ELISA assays using the proteins NP[SUB]49-375[/SUB] and HACD could be valuable tools for avian influenza surveillance and as a strategy of DIVA for counteracting the highly pathogenic avian influenza virus H5N1 outbreaks.


[h=4]KEYWORDS:[/h] Avian influenza virus; CD154; Competition ELISA; DIVA; Hemagglutinin

PMID: 26623380 [PubMed - as supplied by publisher] PMCID: PMC4663798 Free PMC Article
 
Back
Top Bottom